Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06886360

Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)

An Open-label Study of Patients with Primary Sclerosing Cholangitis (PSC) Treated with Norucholic Acid Tablets

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Dr. Falk Pharma GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Open-label, multi-center, phase III trial. Oral treatment with 1500 mg norucholic acid in Primary Sclerosing cholangitis

Conditions

Interventions

TypeNameDescription
DRUGnorucholic acid500 mg norucholic acid film-coated tablets; 3 tablets/day

Timeline

Start date
2025-03-01
Primary completion
2027-09-01
Completion
2027-09-01
First posted
2025-03-20
Last updated
2025-03-20

Source: ClinicalTrials.gov record NCT06886360. Inclusion in this directory is not an endorsement.